Patients with glaucoma who displayed an early treatment response to a 10 µg bimatoprost implant and experienced greater than 20% IOP lowering at 12 weeks had significantly greater odds of a long-term IOP response, according to a speaker.
“Those patients that are greater than 20% reduction of their eye pressure actually ended up having a much greater likelihood of having a long-term response,” Jacob W. Brubaker, MD, said at the virtual American Glaucoma Society annual meeting.
Patients with open-angle glaucoma were randomly assigned to receive 10 µg or 15 µg Durysta (bimatoprost
Uncategorized